Dr. Stephen Simko was awarded the Nesbit Prize in Clinical Science from the Histiocytosis Association, in conjunction with the Histiocyte Society. He received the award at the Histiocyte Society’s annual meeting in October.

The prize recognizes physicians or scientists who are conducting clinical research related to the therapy, biology or pathogenesis of one of the histiocytic disorders.

Dr. Simko has been a leader in the development of clinical research for the treatment of leukemia and has a special interest in histiocytosis, bone tumors and the late complications of cancer survivors.

As an international leader in pediatric cancer research and treatment, Texas Children’s Cancer and Hematology Centers are joint programs of Texas Children's Hospital and Baylor College of Medicine. The Centers are dedicated to providing novel therapies and family-centered care to children from infancy through young adulthood with cancer and blood disorders – from the most common to very rare. Texas Children’s Cancer Center is the pediatric program of BCM’s NCI-designated Dan L. Duncan Cancer Center.
Ranked by U.S. News & World Report as the #2 Center in the United States, Texas Children’s Cancer and Hematology Centers treats more childhood cancer and hematology patients than any other program in the U.S., with patients coming from 35 states and 26 countries around the world.